These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Assessing the risks for poliovirus outbreaks in polio-free countries--Africa, 2012-2013. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 Sep; 62(37):768-72. PubMed ID: 24048153 [TBL] [Abstract][Full Text] [Related]
25. Update on vaccine-derived polioviruses--worldwide, January 2008-June 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):1002-6. PubMed ID: 19763076 [TBL] [Abstract][Full Text] [Related]
26. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016. Immunization Systems Management Group of the Global Polio Eradication Initiative MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591 [TBL] [Abstract][Full Text] [Related]
28. Molecular analysis and implications of neurovirulent circulating vaccine-derived poliovirus in Jamaica. A case report and review of literature. Jackson ST; Mullings AM; Booth TF; MacDonald L; Henry SO; Khan CA; McLaughlin PD West Indian Med J; 2008 Nov; 57(5):511-4. PubMed ID: 19565986 [TBL] [Abstract][Full Text] [Related]
29. Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status. Wang HB; Luo HM; Li L; Fan CX; Hao LX; Ma C; Su QR; Yang H; Reilly KH; Wang HQ; Wen N BMC Infect Dis; 2017 Dec; 17(1):742. PubMed ID: 29197328 [TBL] [Abstract][Full Text] [Related]
30. Emergence of vaccine-derived poliovirus type 2 after using monovalent type 2 oral poliovirus vaccine in an outbreak response, Philippines. Alipon SB; Takashima Y; Avagyan T; Grabovac V; Aslam SK; Bayutas B; Logronio J; Wang X; Shrestha A; Neupane S; Roces MC; Apostol LN; Sucaldito N Western Pac Surveill Response J; 2022; 13(2):1-7. PubMed ID: 36276175 [TBL] [Abstract][Full Text] [Related]
31. Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication. Ming LC; Hussain Z; Yeoh SF; Koh D; Lee KS Global Health; 2020 Jul; 16(1):63. PubMed ID: 32677974 [TBL] [Abstract][Full Text] [Related]
35. A developing country perspective on vaccine-associated paralytic poliomyelitis. John TJ Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301 [TBL] [Abstract][Full Text] [Related]
37. Poliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus. Quarleri J Geroscience; 2023 Apr; 45(2):707-717. PubMed ID: 36260265 [TBL] [Abstract][Full Text] [Related]
38. Update on vaccine-derived polioviruses--worldwide, January 2006-August 2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(38):996-1001. PubMed ID: 17898693 [TBL] [Abstract][Full Text] [Related]
39. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria. Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545 [TBL] [Abstract][Full Text] [Related]
40. Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020. Macklin GR; Goel AK; Mach O; Tallis G; Ahmed JA; O'Reilly KM; Grassly NC; Diop OM Vaccine; 2023 Apr; 41 Suppl 1():A19-A24. PubMed ID: 36008232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]